By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- CHICAGO - A phase 1 clinical trial for the first treatment to reset the immune system of multiple sclerosis (MS) patients showed the therapy was safe and dramatically reduced patients' immune systems' reactivity to myelin by 50 to 75 percent, according to new Northwestern Medicine research.
DX Ulcerative Colitis (pancolitis) - May 2011. (Remicade Max/6 wks, LDN, SCD, vitam.)
"Life is like a box of chocolates; you never know what you' gonna get. " by Forrest Gump